Prucalopride Versus Placebo in Gastroparesis
NCT02031081
Diabetes Mellitus, Digestive System Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT Number: NCT01316484
The primary objective of the study is to evaluate how patients with gastroparesis interpret the instructions, item content, and response options of a daily diary questionnaire designed to assess the key symptoms of gastroparesis.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
University of Kansas Medical Center, Kansas City, Kansas, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: 90-minute interview
The cognitive debriefing data will be content analyzed for patient understanding of the concepts in the questionnaire and interpretation of the items' content.
Tranzyme, Inc.
Industry
Protocol for the Patient Understanding (Cognitive Debriefing) of a Modified Gastroparesis Cardinal Symptom Index (GCSI) Daily Diary
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02031081
Diabetes Mellitus, Digestive System Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT02357420
Diabetes Complications, Diabetes Mellitus
Dothan, Alabama, United States
View Trial DetailsNCT02324010
Diabetes Mellitus, Digestive System Diseases
Adelaide, South Australia, Australia
View Trial DetailsNCT01571297
Diabetes Complications, Diabetes Mellitus
Dothan, Alabama, United States
View Trial Details